Intelligence · Clinical Development
Pipeline search results
Programs matching “mononuclear” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "mononuclear" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Suspension of autologous mononuclear cells separated from bone marrow aspirate
The George Institute
diabetic foot syndrome, lower limb ischemia
1 trial -
Autologous (self) mononuclear cells derived from umbilical cord blood
Regeneron Ireland Designated Activity Company (DAC)
Hypoplastic Left Heart Syndrome
1 trial -
Autologous Bone Marrow Mononuclear Cells
Lxo Ireland Designated Activity Company
Peripheral Vascular Diseases
1 trial -
Autologous bone marrow mononuclear cell transplantation
EuroGen Pharmaceuticals Ltd
Spinal Cord Injury
1 trial -
Bone marrow mononuclear cells
Lxo Ireland Designated Activity Company
Chronic Myocardial Ischemia
1 trial -
CMMo/RH/2009
Lxo Ireland Designated Activity Company
Liver Transplant Rejection
1 trial -
Infusion of autologous mononuclear bone marrow cells
Lxo Ireland Designated Activity Company
Idiopathic Dilated Cardiomyopathy
1 trial -
Suspension of autologous mononuclear cells separated from bone marrow aspirate
The George Institute
chronic limb-threatening ischemia, diabetic foot ulcers
1 trial -
Autologous Bone Marrow-derived Mononuclear Cells
Regeneron Ireland Designated Activity Company (DAC)
Congenital Heart Disease
1 trial -
Autologous mononuclear cells
Regeneron Ireland Designated Activity Company (DAC)
Congenital Heart Disease, SRV Dependent
1 trial -
Mononuclear cells
Shandong Provincial Hospital
Chronic Atrophic Gastritis
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.